本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ocular Therapeutix

10.24
+0.04500.44%
成交量:19.56萬
成交額:199.82萬
市值:22.41億
市盈率:-7.24
高:10.32
開:10.21
低:10.16
收:10.19
52周最高:16.44
52周最低:6.23
股本:2.19億
流通股本:1.85億
量比:0.44
換手率:0.11%
股息:- -
股息率:- -
每股收益(TTM):-1.4140
每股收益(LYR):-1.4203
淨資產收益率:-72.99%
總資產收益率:-34.95%
市淨率:4.31
市盈率(LYR):-7.21

資料載入中...

2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/25

重要事件披露

Form 8-K - Current report
2023/12/29

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/22

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/19

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/14

重要事件披露

Form 8-K - Current report
2023/11/14

SEC問詢函

Form CORRESP - Correspondence
2023/11/07

重要事件披露

Form 8-K - Current report
2023/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]